{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:27:18Z","timestamp":1773260838546,"version":"3.50.1"},"reference-count":37,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Patients with rheumatoid arthritis (RA) have an increased cardiovascular risk not completely explained by traditional cardiovascular risk factors. If the proatherogenic lipid profile observed in active and untreated RA improves by effectively treating RA without the use of a lipid-lowering agent, other nonconventional cardiovascular lipid risk factors may be implicated. We evaluated conventional lipid risk factors and lipoprotein(a) in treated patients with RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>This cross-sectional study was conducted in 122 patients with RA. Lipid profiles of patients were compared with a control group, consisting of a population-based study cohort (DRECE study), matched for sex, age, menopausal status, and body mass index. Excess lipoprotein(a) was defined by a serum concentration &gt; 0.3 g\/l.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>High-density lipoprotein cholesterol (HDL-c) concentrations were higher in pre- and postmenopausal women with RA than in controls (p = 0.023 and p \u2264 0.001, respectively). All RA patients had significantly lower levels of apolipoprotein B and apolipoprotein B\/apolipoprotein A-I ratio, and postmenopausal women with RA also had significantly lower low-density lipoprotein cholesterol and total cholesterol levels than their respective controls. No differences were observed in serum levels of apolipoprotein A-I and triglyceride. All RA patients had higher lipoprotein(a) values than controls. Fourteen men (56%) and 10 (53%) and 42 (54%) pre- and postmenopausal women with RA, respectively, had hyperlipoproteinemia(a).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>RA patients undergoing antirheumatic therapy display a nonatherogenic conventional lipid profile, i.e., high HDL-c, low apolipoprotein B concentrations, and low apolipoprotein B\/apolipoprotein A-I ratio. This may be counteracted by the high prevalence of hyperlipoproteinemia(a) observed in these patients.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.080928","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T01:05:56Z","timestamp":1239843956000},"page":"1365-1370","source":"Crossref","is-referenced-by-count":32,"title":["Conventional Lipid Profile and Lipoprotein(a) Concentrations in Treated Patients with Rheumatoid Arthritis"],"prefix":"10.3899","volume":"36","author":[{"given":"CARMEN","family":"GARC\u00cdA-G\u00d3MEZ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOAN M.","family":"NOLLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOSEP","family":"VALVERDE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUAN A.","family":"G\u00d3MEZ-GERIQUE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAR\u00cdA J.","family":"CASTRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XAVIER","family":"PINT\u00d3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"2018112909200061000_36.7.1365.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.88"},{"key":"2018112909200061000_36.7.1365.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20878"},{"key":"2018112909200061000_36.7.1365.3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel253"},{"key":"2018112909200061000_36.7.1365.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.03.004"},{"key":"2018112909200061000_36.7.1365.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000054612.26458.B2"},{"key":"2018112909200061000_36.7.1365.6","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#"},{"key":"2018112909200061000_36.7.1365.7","first-page":"1766","article-title":"Indications for lowering LDL cholesterol in rheumatoid arthritis: An unrecognized problem","volume":"33","author":"Soubrier","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909200061000_36.7.1365.8","first-page":"1701","article-title":"Lipid profiles in untreated patients with rheumatoid arthritis","volume":"26","author":"Park","year":"1999","journal-title":"J Rheumatol"},{"key":"2018112909200061000_36.7.1365.9","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis \u2014 the Third National Health and Nutrition Examination Survey","volume":"32","author":"Choi","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909200061000_36.7.1365.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01186-5"},{"key":"2018112909200061000_36.7.1365.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0438-0"},{"key":"2018112909200061000_36.7.1365.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.12.015"},{"key":"2018112909200061000_36.7.1365.13","first-page":"1619","article-title":"Cardiovascular risk factors in Chilean patients with rheumatoid arthritis","volume":"29","author":"Cisternas","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909200061000_36.7.1365.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"2018112909200061000_36.7.1365.15","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"2018112909200061000_36.7.1365.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"2018112909200061000_36.7.1365.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2018112909200061000_36.7.1365.18","first-page":"730","article-title":"Lipid profile of the Spanish population: The DRECE (diet and risk of cardiovascular disease in Spain) study","volume":"113","author":"Gomez-Gerique","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"2018112909200061000_36.7.1365.19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0025-7753(00)71675-7","article-title":"Diet and Cardiovascular Risk in Spain Study (DRECE II). Description of the evolution of cardiovascular profile","volume":"115","author":"Gutierrez Fuentes","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"2018112909200061000_36.7.1365.20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2018112909200061000_36.7.1365.21","doi-asserted-by":"publisher","DOI":"10.1157\/13048328"},{"key":"2018112909200061000_36.7.1365.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61076-4"},{"key":"2018112909200061000_36.7.1365.23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11883-003-0081-3","article-title":"Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications","volume":"5","author":"Scanu","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"2018112909200061000_36.7.1365.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(02)00046-3"},{"key":"2018112909200061000_36.7.1365.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.01994.x"},{"key":"2018112909200061000_36.7.1365.26","first-page":"2440","article-title":"Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab","volume":"33","author":"Spanakis","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909200061000_36.7.1365.27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11883-000-0021-4","article-title":"Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype","volume":"2","author":"Austin","year":"2000","journal-title":"Curr Atheroscler Rep"},{"key":"2018112909200061000_36.7.1365.28","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5"},{"key":"2018112909200061000_36.7.1365.29","doi-asserted-by":"publisher","DOI":"10.1086\/315611"},{"key":"2018112909200061000_36.7.1365.30","doi-asserted-by":"crossref","first-page":"M137","DOI":"10.1093\/gerona\/50A.3.M137","article-title":"Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys","volume":"50","author":"Ettinger","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2018112909200061000_36.7.1365.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.22482"},{"key":"2018112909200061000_36.7.1365.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.20853"},{"key":"2018112909200061000_36.7.1365.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.008"},{"key":"2018112909200061000_36.7.1365.34","unstructured":"Steiner G Urowitz MB . Lipid profiles in patients with rheumatoid arthritis: Mechanisms and the impact of treatment. Semin Arthritis Rheum 2008 Apr 4. [Epub ahead of print]"},{"key":"2018112909200061000_36.7.1365.35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.32.382"},{"key":"2018112909200061000_36.7.1365.36","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:3<443::AID-ANR8>3.0.CO;2-Q"},{"key":"2018112909200061000_36.7.1365.37","first-page":"1746","article-title":"Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles","volume":"31","author":"Yoo","year":"2004","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.080928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:47:15Z","timestamp":1589723235000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.080928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.3899\/jrheum.080928"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.080928","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}